Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06785168

The Effect of Resistance Training on Sarcopenia in Older Heart Failure Patients

The Effects of Machined Based Resistance Training in Older Patients With Chronic Heart Failure With Sarcopenia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
146 (estimated)
Sponsor
Kieu Nguyen Dang Phuong · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The goal of study is to evaluate the effects of an eight-week machine-based resistance training program on managing sarcopenia in older outpatients with chronic heart failure (HF) at Military Hospital 175.

Detailed description

The participants will be randomly assigned to two groups: One group received machine-based resistance training (MRT) at the hospital, while the other group received usual care (US). The outcomes will be measured in the participants after 8 weeks including handgrip strength, gait speed, performance on the five-times sit-to-stand test.

Conditions

Interventions

TypeNameDescription
OTHERMachine-based Resistance TrainingThe participants will receive HF treatment as prescribed by cardiologists. If participants have any additional medical conditions, their existing medications or treatments should continue. They are also asked to maintain their usual physical activity, exercise routines, and dietary habits, without making changes outside of the study intervention. At the beginning, patients participating in resistance training should complete a pretest of one-repetition maximum (1-RM) to assess muscle strength, which will be used by a professional physical therapist to develop an individualized prescription. The specific movements are as follows: (1) leg press and (2) calf raise by Proxomed Compass 540 (Germany); (3) leg curl, (4) chest press, (5) push up, (6) seated row by HUR machine (US). During the 8 weeks, subjects will train 3 non-consecutive days/week with intensity 30%1-RM to 60% 1-RM, 3 sets/one excercise with 8-12 repetitions.

Timeline

Start date
2024-12-24
Primary completion
2026-12-31
Completion
2027-12-31
First posted
2025-01-21
Last updated
2026-02-17

Locations

2 sites across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT06785168. Inclusion in this directory is not an endorsement.